Ligand validation:4A4L

TLA: L(+)-TARTARIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4A4L_TLA_A_1330	54%	2%	0.184	0.951	4.11	2.76	4	7	0	0	100%	1
2YAC_TLA_A_503	68%	2%	0.115	0.927	3.98	2.87	5	8	0	0	100%	1
3KB7_TLA_A_400	48%	41%	0.188	0.931	1.13	1.15	-	1	0	0	100%	1
4A4O_TLA_A_1331	47%	2%	0.194	0.934	3.85	2.89	4	9	1	0	100%	1
2BLR_TLA_A_1207	100%	32%	0.023	0.994	1.77	0.94	2	-	0	0	100%	1
3WOU_TLA_A_302	100%	45%	0.029	0.996	1.18	0.96	-	-	0	0	100%	1
2VI4_TLA_A_1207	100%	41%	0.029	0.994	1.41	0.88	1	-	0	0	100%	1
3AL7_TLA_A_220	100%	43%	0.033	0.997	1.44	0.78	1	-	0	0	100%	1
5YYP_TLA_A_301	100%	26%	0.032	0.996	1.6	1.38	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.